Cargando…

Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

BACKGROUND: HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalwanga, Damalie, Musiime, Victor, Bangirana, Paul, Nishiguchi, Erika Phelps, Kiggwe, Andrew, Ssesanga, Titus, Ssenkusu, John M., Musoke, Philippa, Cusick, Sarah E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073947/ https://www.ncbi.nlm.nih.gov/pubmed/33902506 http://dx.doi.org/10.1186/s12887-021-02676-2

Ejemplares similares

Mortality among children under five years admitted for routine care of severe acute malnutrition: a prospective cohort study from Kampala, Uganda
por: Nalwanga, Damalie, et al.
Publicado: (2020)

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
por: Pérez-Valero, Ignacio, et al.
Publicado: (2013)

Attitudes, Practices and Understanding of health workers and caregivers regarding the relationship between severe pneumonia and malnutrition in children: A Qualitative Study
por: Nalwanga, Damalie, et al.
Publicado: (2023)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
por: Musana, Hellen, et al.
Publicado: (2021)

Children living with HIV: a narrative review of recent advances in pediatric HIV research and their implications for clinical practice
por: Nalwanga, Damalie, et al.
Publicado: (2022)

Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens
por: Martini, Salvatore, et al.
Publicado: (2023)

Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
por: Nuwagira, Edwin, et al.
Publicado: (2021)

Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon
por: Njom Nlend, Anne Esther, et al.
Publicado: (2019)

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
por: Sarkar, Ambalika, et al.
Publicado: (2020)

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060
por: Hobbs, Charlotte V., et al.
Publicado: (2016)

Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
por: Babii, Oleg, et al.
Publicado: (2021)

Viral Protease Inhibitors
por: Anderson, Jeffrey, et al.
Publicado: (2009)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases
por: van der Linden, Lonneke, et al.
Publicado: (2014)

A study of proteases and protease-inhibitor complexes in biological fluids
por: Granelli-Piperno, A, et al.
Publicado: (1978)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2015)

Identification of Proteases and Protease Inhibitors in Allergenic and Non-Allergenic Pollen
por: Höllbacher, Barbara, et al.
Publicado: (2017)

Fingerprinting of Proteases, Protease Inhibitors and Indigenous Peptides in Human Milk
por: Thesbjerg, Martin Nørmark, et al.
Publicado: (2023)

Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin
por: Hartman, Alwin M., et al.
Publicado: (2015)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
por: López-Cortés, Luis F., et al.
Publicado: (2016)

Tipranavir in the Protease Inhibitors Arena
por: Vergani, Barbara, et al.
Publicado: (2012)

Alphavirus Nonstructural Proteases and Their Inhibitors
por: Bissoyi, Akalabya, et al.
Publicado: (2017)

Proteinaceous cysteine protease inhibitors
por: Dubin, G.
Publicado: (2005)

High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania – A prospective cohort study
por: Bircher, Rahel E., et al.
Publicado: (2020)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

Effect of the African Traditional Medicine, Sutherlandia frutescens, on the Bioavailability of the Antiretroviral Protease Inhibitor, Atazanavir
por: Müller, Adrienne C., et al.
Publicado: (2013)

Antiretroviral protease inhibitors induce features of cellular senescence that are reversible upon drug removal
por: Kuehnemann, Chisaka, et al.
Publicado: (2022)

Strategies to Reduce Mortality Among Children Living With HIV and Children Exposed to HIV but Are Uninfected, Admitted With Severe Acute Malnutrition at Mulago Hospital, Uganda (REDMOTHIV): A Mixed Methods Study
por: Musiime, Victor, et al.
Publicado: (2022)

The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes
por: Kryvalap, Yury, et al.
Publicado: (2022)

The roles of plant proteases and protease inhibitors in drought response: a review
por: Moloi, Sellwane Jeanette, et al.
Publicado: (2023)

Novel inhibitors and activity-based probes targeting serine proteases
por: Ferguson, Timothy E. G., et al.
Publicado: (2022)

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis
por: Mathis, Sandra, et al.
Publicado: (2011)

A protease inhibitor unsticks cells
por: LeBrasseur, Nicole
Publicado: (2003)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

Role of Protease-Inhibitors in Ocular Diseases
por: Pescosolido, Nicola, et al.
Publicado: (2014)

Protease Inhibitor Use in COVID-19
por: Song, Yueqi, et al.
Publicado: (2020)

The Antiviral Potential of Host Protease Inhibitors
por: Steinmetzer, Torsten, et al.
Publicado: (2018)

Gene expression and activity of digestive proteases in Daphnia: effects of cyanobacterial protease inhibitors
por: Schwarzenberger, Anke, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h6482s8n8dmf1dtc54mr8kbe1u